Three-Statement Breakdown
REVENUE UP
Revenue rose 4.9% year over year to $12.6B, and carried a 10.9% net margin.
REVENUE
+4.9%
12,608
GROSS PROFIT
—
—
NET INCOME
+7.0%
1,379
EPS (DILUTED)
+7.4%
$5.10
| Income statement | 24-10 | 25-01 | 25-04 | 25-07 | 25-11 | 26-02 | 26-05 | QoQ | YoY | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11,144 | 8,508 | 12,763 | 12,018 | 12,394 | 9,611 | 13,369 | 12,608 | -5.7% | +4.9% | |
| Research & development | (625) | (526) | (549) | (556) | (680) | (554) | (583) | (567) | -2.7% | +2.0% | |
| SG&A | (1,231) | (972) | (1,197) | (1,217) | (1,276) | (972) | (1,209) | (1,220) | +0.9% | +0.2% | |
| Interest expense | (870) | (829) | (784) | (794) | (762) | (719) | (712) | (710) | -0.3% | -10.6% | |
| Income tax | (249) | (27) | (539) | (339) | (354) | (196) | (518) | (529) | +2.1% | +56.0% | |
| Net income | 1,245 | 869 | 1,804 | 1,289 | 1,065 | 656 | 1,773 | 1,379 | -22.2% | +7.0% | |
| EPS (diluted) |
NOT DISCLOSED
10-Q
|
— | $3.19 | $6.64 | $4.75 | — | $2.42 | $6.55 | $5.10 | -22.1% | +7.4% |
Click a line to select it — Enter or the EXPAND pill folds out its quarter-by-quarter history.
No comparable bridge for this view yet.
↹ CLICK A LINE TO SELECT · ⌘F FIND LINE ITEM
SRC 10-Q FILED 2026-08-27 ↗